X
20
3m Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INVESTIGATIONAL NEW DRUG PROCEDURES, with a corresponding US DMF Number 570.
Remarkably, this DMF maintains an Inactive status since its submission on May 28, 1963, highlighting commitment to regulatory compliance.